Dr. Jack S. Resneck Jr., MD

Dr. Resneck practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Resneck's NPI, 1760449292, was assigned on April 27, 2006. Dr. Resneck graduated from UCSF School of Medicine in 1997. Dr. Resneck holds California license A66722.

Dr. Resneck's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Resneck's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Resneck to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Resneck practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Resneck's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Resneck is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Resneck's licenses on file in 2 states: California and Louisiana.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, hives, itchy rashes and joint cyst among the conditions Dr. Resneck treats.

CMS data shows 836 Medicare services from Dr. Resneck across 11 procedure codes in 2024, for 181 Medicare patients. Medicare paid $32,409 for them. Every service was in an office.

CMS counts 181 Medicare patients who saw Dr. Resneck in 2024. The largest group is 75 to 84, with 84 patients. 70% of them have high cholesterol, and 57% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Resneck's median patient age at 70, with 41% women.

In 2024, Dr. Resneck wrote 221 Medicare Part D claims for 97 patients. 93% of them were for generic drugs. CMS names the drug for 147 of them, across 6 drugs with 11 or more claims each, at $6,294 in total drug cost. In 2023, CMS named 138 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Resneck for performance year 2024, reported as part of a group. Dr. Resneck accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 283 procedures of removal of skin lesions by Dr. Resneck, more than 82% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 37 papers to Dr. Resneck, published from 2006 to 2021. 2017 was the busiest year, with 3. The most frequent topics are Dermatology, Appointments and Schedules and Waiting Lists. Dr. Resneck has published most often in J Am Acad Dermatol. Dr. Resneck's most frequent co-authors are Jack S. Resneck, MD, Jean L. Bolognia, MD and Julie A. Hodge, MD.

CMS Open Payments shows 1 general payment to Dr. Resneck from 1 drug or device company in 2017. Consulting fees make up the largest share, 100% of the total. Dr.Reddy's Laboratories,Inc. paid the most, $450.

Dmand AI lists 1 award for Dr. Resneck, most recently CMS Stage 1 EHR in 2013.

Dr. Resneck graduated from UCSF School of Medicine in 1997.

Dr. Resneck is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.